Partnerships & alliances

Sandia and the University of New Mexico’s jointly developed protocell technology was licensed to startup Alpine Biosciences in July 2014. Oncothyreon Inc. subsequently acquired Alpine Biosciences in August. The license and acquisition will accelerate the technology’s clinical development for treating currently intractable diseases. UNM led licensing for cancer therapies while Sandia retains rights to seek partners for national security applications. Sandia and UNM will share in any royalties that result from successful commercialization. The Sandia-UNM relationship is a partnerships model Sandia will replicate with other university partners to increase IP deployment. (1900) IHNS [RGCBD]